JOURNAL OF INFECTION, cilt.76, sa.1, ss.20-37, 2018 (SCI-Expanded)
Objectives: Fluoroquinolone (FQ) prophylaxis was recommended in 2005 by European Conference on Infections in Leukemia (ECIL) for patients with prolonged neutropenia. In consideration of a worldwide increase in antibiotic resistance, the issue of FQ prophylaxis during neutropenia was re-evaluated.